NPS

The rapid emergence of a large number of New Psychoactive Substances on the global drug market poses a significant risk to public health and a challenge to drug policy. Often, little is known about the adverse health effects and social...

Overview A new psychoactive substance (NPS) is defined as 'a new narcotic or psychotropic drug, in pure form or in preparation, that is not controlled by the United Nations drug conventions, but which may pose a public health threat...

Today, the European Commission has adopted measures to control two harmful new psychoactive substances (NPS) across the EU. The substances in question — 3-methylmethcathinone (3-MMC) and 3-chloromethcathinone (3-CMC) — are both synthetic...

Abstract Introduction and objective: Assessing the abuse potential of new substances with central nervous system activity is essential for preventing possible risks of misuse and addiction. The same methodology is recommended for the...

1-(3-Chlorophenyl)-2-(methylamino) propan-1-one (3-chloromethcathinone, 3-CMC) is a synthetic cathinone stimulant. It is a ring-substituted cathinone, which is structurally related to methcathinone and 4-chloromethcathinone (4-CMC). The...

This Special Issue explores new drug and behavioural trends during the Covid-19 Pandemic. We welcome multidisciplinary contributions aimed at enhancing the understanding of how “physical distancing” and other radical changes in our...

On April 27, 2021, UNODC Regional Office for Central Asia held a training seminar for specialists of the republican and regional levels responsible for drug dependence treatment and HIV prevention services in the Republic of Uzbekistan. The...